Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Bicara Therapeutics (BCAX) Q3 2025 Earnings
BCAX
12
Aug
Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.6
-1.18
-0.75
-0.33
Details
Expected EPS
-0.554043
Actual EPS
-0.5
Surprise EPS
0.05
Surprise Percent
+9.75%
Description
Bicara Therapeutics (BCAX) has reported earnings of -0.5 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login